Skip to main content

Publications Digest

27
Mar 2026

Publication Digest: Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real-World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next Steps

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Cresswell et al. reviewed global regulatory and HTA policies on real-world evidence use.
25
Mar 2026

EU HTA Publication Digest: Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Julian et al. developed a stakeholder-centric framework of key performance indicators to support implementation of the EU HTA Regulation across Europe using a modified Delphi approach.
23
Mar 2026

Publication Digest: The role of European HTA agencies in relation to the governance of medical technologies: a discourse analysis of academic literature

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Michels et al. explored how academic literature conceptualizes the role of HTA agencies in governing medical technologies across Europe.
11
Mar 2026

EU HTA Publication Digest: European Joint Clinical Assessment PICO Scoping Process: Analysis of Current Approaches and Recommendations

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, D'Oca et al. analyzed current practices in the PICO scoping process used to define the scope of Joint Clinical Assessments under the EU HTA Regulation.
09
Mar 2026

Publication Digest: Toward a Harmonized Health Technology Assessment Framework for Digital Health Technologies in Europe

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Tsiasiotis et al. explored stakeholder perspectives on the development of a harmonized health technology assessment (HTA) framework for digital health technologies (DHTs) in Europe within the Horizon Europe funded EDiHTA project.
06
Mar 2026

Health Economic Publication Digest: Priority Measures at the intersection of clinical practice, health economics and health policy: an ESC pilot to support implementation of recommendations

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Timmermans et al. presented a European Society of Cardiology (ESC) pilot framework designed to integrate economic and implementation considerations alongside traditional efficacy metrics for decision-making.
04
Mar 2026

EU HTA Publication Digest: The Early Experiences of Health Technology Assessment Bodies in the Implementation of the European Union Health Technology Assessment Regulation for High-Risk Medical Devices: A Qualitative Study

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Alshaikh et al. explored how national HTA bodies across 11 EU Member States are preparing for the implementation of the EU Health Technology Assessment Regulation (HTAR) and the introduction of Joint Clinical Assessments (JCAs) for high-risk medical devices and IVDs.
02
Mar 2026

Publication Digest: The AMSTAR 2 publication lacks explicit instructions on how to assess the appropriateness of statistical methods (item 11) and publication bias (item 15) and does not reflect advances in meta-analysis

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Spineli critically examined limitations of the AMSTAR 2 appraisal tool, which is used to assess the methodological quality of systematic literature reviews.
27
Feb 2026

Health Economic Publication Digest: Mapping Methodologies for Economic Evaluation of Digital Health Technologies: A Scoping Review

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Santos et al. systematically reviewed and mapped 26 frameworks for the economic evaluation of digital health technologies (DHTs) to identify methodological inconsistencies and inform more robust standards.
25
Feb 2026

EU HTA Publication Digest: Joint Clinical Assessments in Europe: Implications for Market Access, Reimbursement, and National HTA Alignment

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Dang et al. reviewed the implementation of Joint Clinical Assessments under the EU HTAR (Regulation 2021/2282), analyzing methodological, regulatory, and stakeholder implications across EU Member States.
23
Feb 2026

Publication Digest: Methodological review reveals essential gaps and inconsistencies in clinical claims, effects, and outcomes in HTA reviews of diagnostic tests

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Dinnes et al. conducted a methodological review of 45 HTAs (50 review questions) of diagnostic tests to assess how clearly clinical pathways, test claims, and outcomes are specified within existing HTAs.